Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-01-30

Clinical Trial Update: Safety and Efficacy Placebo Controlled Study of ATH008 Cream in PPES Patients Secondary to Capecitabine [Phase 2]

View source ↗

Summary

Phase 2 placebo-controlled study evaluating the safety and efficacy of ATH008 Cream in patients with palmar-plantar erythrodysesthesia syndrome induced by capec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ATH008 Cream

Snippet

Sponsor: Advancell - Advanced In Vitro Cell Technologies, S.A. | Conditions: Palmar-Plantar Erythrodysesthesia Syndrome | Phase 2 | Status: COMPLETED